S. Ayse Ornek Et Al. , "An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria," International Immunopharmacology , vol.112, 2022
Ayse Ornek, S. Et Al. 2022. An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria. International Immunopharmacology , vol.112 .
Ayse Ornek, S., Orcen, C., Church, M. K., & Kocaturk, E., (2022). An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria. International Immunopharmacology , vol.112.
Ayse Ornek, Sinem Et Al. "An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria," International Immunopharmacology , vol.112, 2022
Ayse Ornek, Sinem A. Et Al. "An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria." International Immunopharmacology , vol.112, 2022
Ayse Ornek, S. Et Al. (2022) . "An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria." International Immunopharmacology , vol.112.
@article{article, author={Sinem Ayse Ornek Et Al. }, title={An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria}, journal={International Immunopharmacology}, year=2022}